Hormone Replacement Therapy: What Has Changed and What We Know Now

Hormone Replacement Therapy: What Has Changed and What We Know Now

Hormone Replacement Therapy: What Has Changed and What We Know Now 1920 1280 Gary Ruelas, D.O., Ph.D.

As women move through perimenopause and menopause, symptoms like hot flashes, night sweats, sleep changes, and mood shifts can affect daily life. Hormone replacement therapy (HRT) is one option used to help manage these symptoms, but the conversation around HRT has shifted a lot over the years.

HRT has been part of women’s health for decades. In the early 2000s, findings from the Women’s Health Initiative (WHI) raised concerns about cancer and other health risks, and prescriptions dropped sharply. That fear shaped how many women and doctors viewed hormone therapy for years afterward.

Today, the conversation is changing again. Looking back at HRT’s history helps explain what happened, what concerns remain today, and why hormone therapy is increasingly seen as one part of a broader, individualized approach to a woman’s health.

A Brief History of Hormone Replacement Therapy

  • 1890s–1930s: Merck produced the first ovarian extract, Ovariin, in the 1890s. In 1933, Emmenin became the first human-identical hormone therapy.
  • 1940s: The FDA approved Premarin, a conjugated equine estrogen derived from pregnant mare urine.
  • 1960s: Gynecologist Robert Wilson published the bestseller Feminine Forever, reframing menopause as a “deficiency disease.” Prescriptions skyrocketed.
  • 1970s–1980s: Estrogen-only therapy was linked to a higher risk of endometrial cancer, causing a temporary drop in use. Adding progestin was later found to reduce this risk significantly.
  • 1990s: Observational studies suggested HRT might protect against heart disease, and it became one of the most widely used therapies in the U.S., with close to 15 million women on it.
  • 2002: The Women’s Health Initiative trial was halted early after data linked HRT to a higher risk of cancer and other health problems. Prescriptions dropped by more than 30% in the years that followed.

Old woman being examined by doctor.

Looking Beyond the Hormone Scare

The Women’s Health Initiative ran for years to study how hormone therapy affected women’s long-term health. In 2002, it was stopped after the data pointed to a higher risk of cancer and other health problems. That decision set off what’s often called the “hormone scare,” and shaped how HRT was viewed for the next two decades.

Since then, researchers have taken a closer look at the study and the way its findings were applied. One concern was the broad age range of women included and the use of set hormone doses rather than treatment being adjusted for each woman’s age, response, or ability to tolerate it.

That one-size-fits-all dosing hit older women the hardest. Women 70 and older were given the same dose as women in their 40s, and many couldn’t tolerate it well. This age group saw the largest increase in cancer risk.

Younger women showed a different pattern in some of the later data, with risks that were closer to those seen in women who were not taking HRT. This helped reopen the conversation around whether age, timing, dosing, and monitoring should play a larger role in hormone therapy.

This doesn’t mean HRT is risk-free. But it does suggest that dosing and monitoring matter just as much as the decision to use HRT in the first place.

For many women, HRT can help ease hot flashes, night sweats, sleep disruption, and mood changes tied to hormonal shifts. The potential benefits and concerns should be weighed together, with treatment adjusted as a woman’s needs and health change over time.

Managing HRT in Orange County as Part of Whole-Person Care

At Integrative Medical Institute of Orange County, hormone replacement therapy is never used in isolation. Dr. Ruelas has been managing HRT for decades, an approach that has been featured in several books, including Suzanne Somers’ Ageless. Over that time, he has learned how to test, adjust, and monitor hormones so that treatment fits each woman rather than following a general protocol.

Dr. Ruelas sees hormones as a key part of helping women feel better, but not the complete answer on their own. He takes a whole mind-body approach to HRT, looking at the gut-brain pathway, sleep, digestion, and inflammation alongside hormone therapy to help manage symptoms. Current medications, health risks, health status, and the specific form and method of hormone delivery all factor into the plan.

He also recognizes the role hormones play from conception through menopause, and how closely that ties into the body’s broader mind-body process. By looking at the whole person rather than a single hormone level, we can better understand where HRT fits into each woman’s care.

Contact us to learn more about hormone replacement therapy and our individualized approach to care.

Disclaimer: This information is for educational purposes only and does not constitute medical advice.

mm

Gary Ruelas, D.O., Ph.D.

Dr. Ruelas holds doctoral degrees and is licensed to practice in both medicine and psychology. He approaches his patients by gathering and analyzing data differently from other physician’s moving away from a disease model to a holistic functional model. Read Bio

All articles by : Gary Ruelas, D.O., Ph.D.